What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Enzyme
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Insulin resistance, Adipose tissue and Lipidomics.
His Internal medicine research incorporates elements of Microbiome and Diabetes mellitus.
As a part of the same scientific family, Matej Orešič mostly works in the field of Endocrinology, focusing on Mitochondrion and, on occasion, Mitochondrial myopathy.
His work carried out in the field of Insulin resistance brings together such families of science as Saturated fatty acid, Inflammation and Polyunsaturated fatty acid.
His Lipidomics study combines topics from a wide range of disciplines, such as Computational biology, Identification and Metabolic Stress.
The study incorporates disciplines such as Body mass index, Type 2 diabetes and Gastrointestinal Microbiome in addition to Obesity.
His most cited work include:
- MZmine 2: Modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data (1667 citations)
- Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist (1022 citations)
- Human gut microbes impact host serum metabolome and insulin sensitivity (744 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Endocrinology, Lipidomics, Metabolomics and Lipid metabolism.
The various areas that Matej Orešič examines in his Internal medicine study include Diabetes mellitus and Type 1 diabetes.
His study in Adipose tissue, Insulin, Lipogenesis, Carbohydrate metabolism and Lipolysis is done as part of Endocrinology.
He interconnects Schizophrenia and Cholesterol in the investigation of issues within Lipidomics.
His studies in Metabolomics integrate themes in fields like Computational biology, Systems biology and Disease.
His Lipid metabolism study improves the overall literature in Biochemistry.
He most often published in these fields:
- Internal medicine (60.09%)
- Endocrinology (45.83%)
- Lipidomics (36.62%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (60.09%)
- Endocrinology (45.83%)
- Disease (14.04%)
In recent papers he was focusing on the following fields of study:
Matej Orešič spends much of his time researching Internal medicine, Endocrinology, Disease, Lipid metabolism and Lipidomics.
His Psychosis research extends to Internal medicine, which is thematically connected.
Endocrinology and Oleoylethanolamide are frequently intertwined in his study.
Matej Orešič combines subjects such as Metabolome and Exposome, Environmental health with his study of Disease.
His Lipid metabolism research is multidisciplinary, relying on both Type 1 diabetes and Immunology.
His Lipidomics research integrates issues from Computational biology, Systems biology, Disease biomarker and Metabolomics.
Between 2019 and 2021, his most popular works were:
- Hydroxysteroid 17-β dehydrogenase 13 variant increases phospholipids and protects against fibrosis in nonalcoholic fatty liver disease (21 citations)
- Hydroxysteroid 17-β dehydrogenase 13 variant increases phospholipids and protects against fibrosis in nonalcoholic fatty liver disease (21 citations)
- Hydroxysteroid 17-β dehydrogenase 13 variant increases phospholipids and protects against fibrosis in nonalcoholic fatty liver disease (21 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Enzyme
Internal medicine, Endocrinology, Fibrosis, Fatty liver and Mass spectrometry are his primary areas of study.
His Internal medicine study combines topics in areas such as Offspring, Pregnancy and Type 1 diabetes.
His Endocrinology study is mostly concerned with Insulin resistance, Steatosis, Islet, Lithocholic acid and Lipid profile.
His work deals with themes such as Adiponutrin, NEFA, Fatty acid and Adipose tissue, Lipolysis, which intersect with Insulin resistance.
His Fatty liver research is multidisciplinary, incorporating perspectives in Biomarker, Cochrane Library and Liver biopsy.
His research in Mass spectrometry focuses on subjects like Detection limit, which are connected to Acetone.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
